A significant interaction ( P = @ ) suggests a lower coronary heart disease risk in the obese for lisinopril versus chlorthalidone ( hazard ratio @ , @ % confidence interval @-@ @ ) and a significant interaction ( P = @ ) suggests a higher risk of end-stage renal disease for amlodipine versus chlorthalidone in obese participants ( hazard ratio @ , @ % confidence interval @-@ @ ) .